“Through our unwavering commitment to patient care, education, research, and advocacy, PIDS will continue to lead with impact, integrity, and a shared dedication to improving the lives of children everywhere.”
Dr. Deb Palazzi, PIDS President

PIDS exists to promote the health of children through the prevention and control of infectious diseases worldwide. We do this through the discovery (innovation) and implementation of strategies to prevent and treat infectious diseases around the world (impact) while training future generations of pediatric infectious diseases specialists. As we do this, we are committed to building a professional society that reflects the diversity of those we serve (inclusion). It’s who we are.

About PIDS

Who we are

PIDS (Pediatric Infectious Diseases Society) is the world’s largest organization of professionals dedicated to the treatment, control and eradication of infectious diseases affecting children. Membership is comprised of physicians, doctoral-level scientists and others in the field of pediatric infectious diseases or related disciplines through clinical practice, research, teaching and/or administrative activities.

PIDS works closely with many professional organizations that share its goals, including the European Society for Pediatric Infectious Diseases, the Society for Pediatric Infectious Diseases in Latin America, The Asian Society of Pediatric Infectious Diseases, the Infectious Diseases Society of America and the American Academy of Pediatrics.

Join Us

Membership

Membership in PIDS is open to physicians, doctoral-level scientists and other persons who have training or are in the course of training in infectious diseases or its related disciplines, and who are identified with the discipline of pediatric infectious diseases or its related activities. Membership in PIDS allows you to:

  • Receive a yearly online subscription to the official PIDS publication, the Journal of the Pediatric Infectious Diseases Society.
  • Keep abreast of the latest advances in pediatric infectious diseases research findings through educational symposia and membership mailings.
  • Ensure that issues unique to pediatric infectious diseases are thoughtfully considered through collaborative projects with other medical associations.
  • Have a voice in planning the future educational needs of pediatric infectious diseases fellows.

Join the conversation

CDC has issued a Health Alert Network advisory about the risk of severe arboviral neuroinvasive disease among patients who are receiving B cell-depleting or B cell-modulating medications, particularly anti-CD20 monoclonal antibodies (mAbs). Learn more at:

PIDS has issued a statement in response to the Delivering Gold Standard Childhood Vaccine Recommendations for Americans executive order. Read the full statement at: https://pids.org/2026/08/11/pids-response-to-delivering-gold-standard-childhood-vaccine-recommendations-for-americans-executive-order/

IDWeek has launched the IDWeek Daily News blog – your go-to resource for #IDWeek2026 news to prepare you for Washington, D.C.

Check it out today: https://www.idweek.org/idweek-daily-news/

PIDS-SHARPS has partnered with Sustainabil-ID for a pair of talks for the upcoming session of our ongoing series. This special session will be Thursday, August 13 at 1pm ET. Your presenters will be Drs. Emily Spivak and Juhi Shah. Contact us for registration info.

Improving the health of children worldwide through philanthropic support of scientific and educational programs.

This site uses cookies to provide a better experience for you
Ok